Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary…

Overview of attention for article published in Frontiers in Cardiovascular Medicine, June 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Bivalirudin presents favorable safety profile regarding adverse drug reactions, thrombocytopenia and bleeding in Chinese patients with high bleeding risk undergoing PCI: a prospective, multi-center, intensive monitoring study https://t.co/jNs

18 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.